| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/17/2005 | EP1562610A1 Combination therapy with gemcitabine and zd6126 |
| 08/17/2005 | EP1562601A1 Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
| 08/17/2005 | EP1562598A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 08/17/2005 | EP1562591A1 Treatment of mesothelioma |
| 08/17/2005 | EP1562587A2 Novel compositions and methods for the treatment of immune related diseases |
| 08/17/2005 | EP1562580A1 Intermediates for aromatic polyketides as selective anticancer and antiviral agents |
| 08/17/2005 | EP1562579A1 Therapeutic delivery of carbon monoxide |
| 08/17/2005 | EP1562577A1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents |
| 08/17/2005 | EP1562573A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 08/17/2005 | EP1562564A2 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 08/17/2005 | EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 08/17/2005 | EP1466174A4 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/17/2005 | EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 08/17/2005 | EP1389196A4 Three-step conversion of protected taxane ester to paclitaxel |
| 08/17/2005 | EP1316558B1 Tetraphenylbacteriochlorin derivatives and compositions containing the same |
| 08/17/2005 | EP1289951B1 Growth hormone secretagogues |
| 08/17/2005 | EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 08/17/2005 | EP1280757B1 New gamma selective retinoids |
| 08/17/2005 | EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them |
| 08/17/2005 | EP1254141B1 Camptothecin -beta-alanine esters with topoisomerase i inibhition |
| 08/17/2005 | EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP1144385B1 Benzoheterocycles and their use as mek inhibitors |
| 08/17/2005 | EP1073723B1 Ste20-related protein kinases |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 08/17/2005 | EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 08/17/2005 | EP0835128B1 Use of il-11 to treat inflammation |
| 08/17/2005 | CN1656222A Antisense iap nucleobase oligomers and uses thereof |
| 08/17/2005 | CN1656215A Process for producing cytotoxic lymphocyte |
| 08/17/2005 | CN1656116A Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the HPV-16 virus |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1656113A Sialic combined immunoglobulin like agglutinin inhibitors |
| 08/17/2005 | CN1656101A Esters in position 20 of camptothecins |
| 08/17/2005 | CN1656100A Camptothecins with a modified lactone ring |
| 08/17/2005 | CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 08/17/2005 | CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656089A Phenyl-thiophene type vitamin D receptor modulators |
| 08/17/2005 | CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents |
| 08/17/2005 | CN1656078A Aminoindazole derivatives as protein kinase inhibitor |
| 08/17/2005 | CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1656070A Melanocortin receptor ligands |
| 08/17/2005 | CN1655848A Use of new etonogestrel esters |
| 08/17/2005 | CN1655833A Medical devices containing rapamycin analogs |
| 08/17/2005 | CN1655827A Novel use of adenoviruses and nucleic acids coding therefor |
| 08/17/2005 | CN1655825A Non-viral gene delivery system |
| 08/17/2005 | CN1655824A Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same |
| 08/17/2005 | CN1655821A Combination comprising a CDK inhibitor and doxorubicin |
| 08/17/2005 | CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655813A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 08/17/2005 | CN1655811A 组合物及其治疗用途 The composition and therapeutic use |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655801A Method for the protection of endothelial and epithclial cells during chemotherapy |
| 08/17/2005 | CN1655796A Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a SERM |
| 08/17/2005 | CN1655788A 1H-imidazo[4, 5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 08/17/2005 | CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 08/17/2005 | CN1655784A Use of compounds that are effective as selective opiate receptor modulators |
| 08/17/2005 | CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1655771A At least partially degradable films containing an active ingredient and method for the production thereof |
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1655763A Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 08/17/2005 | CN1654666A Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 08/17/2005 | CN1654665A Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 08/17/2005 | CN1654664A Recombinant eukaryon expression vector capable of simultaneously expressing two antisense bFGF and uses thereof |
| 08/17/2005 | CN1654478A Method for preparing polyethylene glycol-modified alpha-interferon 1b |
| 08/17/2005 | CN1654462A Antineoplastic cocoa extracts and methods for making and using the same |
| 08/17/2005 | CN1654074A Anti cancer gene medicinal composition, micromolecule interfere RNA and its screening method |
| 08/17/2005 | CN1654039A Oral formulation of hydroxycamptothecin and its preparation method |
| 08/17/2005 | CN1654037A Dispersible tablet of tamoxifen citrate and preparation method thereof |
| 08/17/2005 | CN1215083C Monoclonal antibody for resisting human liver cancer and its application |
| 08/17/2005 | CN1215070C Use of praeruptorin C in preparing medicine for curing tumor |
| 08/17/2005 | CN1215066C Novel indole derivatives and their use as medicaments |
| 08/17/2005 | CN1215061C Process for preparing anticancer compound, and intermediate |
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/16/2005 | US6930124 Drug for detaching tumor |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930115 Antitumor effect potentiators |
| 08/16/2005 | US6930114 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930102 16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use |
| 08/16/2005 | US6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 08/16/2005 | US6930088 Conformationally constrained backbone cyclized somatostatin analogs |
| 08/16/2005 | US6929955 Interactive system for presenting and eliminating substances |
| 08/16/2005 | US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing |
| 08/16/2005 | US6929818 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/16/2005 | US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein |
| 08/16/2005 | US6929797 Targeted therapeutic delivery of vitamin D compounds |
| 08/16/2005 | US6929012 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/16/2005 | CA2347588C An oxazinone used in preparing taxol and process for preparation thereof |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2206566C Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
| 08/16/2005 | CA2078221C Pharmaceutical compositions comprising taurolidine and/or taurultam |